THSNA Virtual Meeting

Announcement
Thank you for attending THSNA 2026. The virtual meeting is now closed.

Meeting Home >

Live Sessions & Recordings

The following is a schedule of the currently scheduled live sessions and other events. Unless indicated, these events will be recorded for on-demand viewing beginning the day following each event. Please note recording is at the discretion of the speakers and is subject to change.

THURSDAY , MARCH 19, 2026

10:00 AM - 11:00 AM ET	Event Concluded	A Medical Forum for Evidence, Experience, and Interactive Dialogue on Contemporary Considerations in Hemophilia Care (Sponsored by Sanofi)
	Event Concluded	Advancing Hemophilia Care Through TFPI Inhibition: Clinical Evidence and Emerging Real-World Experience With Hympavzi (marstacimab) (Sponsored by Pfizer Inc)
11:15 AM - 12:45 PM ET	View Recording	Is DEI DOA?
1:30 PM - 2:30 PM ET	View Recording	Short Talks - Anticoagulation Clinics in Action: Precision, Protection, and Personalization
	View Recording	Short Talks - Insights Into Thrombosis: Risk Factors, Mechanisms, and Diagnostic Approaches
	View Recording	Short Talks - Integrating Genetics, Immunology, and Diagnostics in Modern Coagulation Medicine / From Genetic Variants to Clinical Pathways: Evolving Insights in Bleeding and Thrombotic Disorders
2:45 PM - 3:45 PM ET	Event Concluded	Exploring a Subcutaneous Treatment Option in Hemophilia Care with HYMPAVZI (marstacimab-hncq) (Sponsored by Pfizer, Inc.)
	Event Concluded	Gene Therapy in Hemophilia B: A Journey of Innovation and Impact (Sponsored by CSL)
	Event Concluded	Real-World Management of Hemophilia A and B: Clinical Cases with Rebalancing and Factor Replacement Therapies (Sponsored by Sanofi)
4:30 PM - 6:00 PM ET	View Recording	Autoimmune Thrombosis Syndromes
	View Recording	Coagulation at the Intersection of Inflammation and Infection
	View Recording	Let's Get This Ironed Out (Impact of Untreated Bleeding in Women/Girls with Bleeding Disorders)
6:45 PM - 8:15 PM ET	View Recording	Antithrombosis Stewardship: High-Impact Opportunities to Optimize Care
	View Recording	Coagulation in Tissue-Specific Injury and Repair
	View Recording	New Therapeutic Targets for Rebalanced Hemostasis: Clinical and Laboratory Implications
8:30 PM - 9:30 PM ET	Event Concluded	Bridging the Gaps: Scientific Updates in ITP, iTTP, and wAIHA (Sponsored by Sanofi)
	Event Concluded	Rethinking hemophilia A management: balancing bleed protection and administration considerations (Sponsored by Novo Nordisk)

FRIDAY , MARCH 20, 2026

10:00 AM - 11:00 AM ET	Event Concluded	Advances in von Willebrand Disease: From Genetics to Prophylaxis (Sponsored by Octapharma)
	Event Concluded	Joint Health and Physical Activity in Patients with Hemophilia A: Panel Discussion and Trivia with Experts (Sponsored by Genentech)
11:15 AM - 12:45 PM ET	View Recording	Challenges in Analyzing Coagulation Parameters--New Solutions to Old Problems?
	View Recording	Clinical Considerations: Aging with a Bleeding Disorder
	View Recording	Don't Forget the Kidneys! Renal Considerations in Thrombosis Pathology and Management
1:30 PM - 2:30 PM ET	View Recording	Short Talks - Anticoagulation Therapy: Best Practices and Complication Management
	View Recording	Short Talks - Diagnosis, Monitoring, and Patient Experience in Bleeding Disorders
	View Recording	Short Talks - Inflammation, Thrombosis, and Organ Injury in Sickle Cell Disease
2:45 PM - 3:45 PM ET	Event Concluded	An Overview of von Willebrand Disease and its Treatment (Sponsored by Takeda)
	Event Concluded	Dive deeper: get to know a treatment option for your patients with hemophilia (Sponsored by Novo Nordisk)
	View Recording	Fine-Tuning the Coagulation Cascade: How We Choose From Expanding Options for Patients With Hemophilia (Supported by Sanofi)
4:30 PM - 5:45 PM ET	View Recording	When Guidelines Hit the Ground: Impact, Implications and Implementation
6:00 PM - 7:30 PM ET	View Recording	Innovative Technologies for Clinical Laboratory Practice
	View Recording	Redefining Guidance on Bleeding Disorders in Sports
	View Recording	Special Site, Special Strategy: Anticoagulation in Complex Vascular Beds
8:15 PM - 9:45 PM ET	View Recording	Between a Clot and a Hard Place- Anticoagulation in High Bleed Risk Population
	View Recording	Kids Are Not Little Adults: Pediatric Considerations in the Hemostasis/Thrombosis Laboratory
	View Recording	Platelets as Agents in Translational Medicine
10:00 PM - 11:00 PM ET	Event Concluded	Cablivi Real-World Evidence in 1,000+ Patients: Why Early Initiation Matters (Sponsored by Sanofi)
	Event Concluded	Navigating a New Frontier in Hemophilia: Evaluating the Utility of Evolving FVIIIa Mimetic Therapies to Address Unmet Needs (This activity is supported by an educational grant from Novo Nordisk, Inc.)

SATURDAY , MARCH 21, 2026

10:00 AM - 11:00 AM ET	Event Concluded	Driving Innovation Forward in Hemophilia B With Gene Therapy: Clinical Conversations on Progress and Guidance on Practical Delivery (PROVIDED BY PEERVIEW LIVE, SUPPORTED BY CSL BEHRING)
11:15 AM - 12:45 PM ET	View Recording	Different Perspectives of Genetics in Hemostasis
	View Recording	Rare Bleeding Disorders
	View Recording	The Clot Thickens: Navigating Thrombosis Risk in Cancer Patients
1:30 PM - 2:30 PM ET	View Recording	Short Talks - Advances in Platelet Disorders: Therapeutics, Diagnostics, and Clinical Management
	View Recording	Short Talks - Coagulation Science and Von Willebrand Factor Research
	View Recording	Short Talks - Emerging Therapeutics and Prophylactic Strategies in Coagulation Disorder
2:45 PM - 4:00 PM ET	View Recording	The Role of Advocacy Organizations in Drug Development, CT design, and Adoption of New Knowledge